COMBINATION ONCOLOGY THERAPIES IN THE EU5: NAVIGATING THE ROAD TO REIMBURSEMENT AND OPTIMIZING UPTAKE IN MALIGNANT MELANOMA

被引：0
|
作者：
Privolnev, Y. [1 ]
Cox, J. [2 ]
Webster, R. [2 ]
机构：
[1] Decis Resources Grp, Toronto, ON, Canada
[2] Decis Resources Grp, London, England
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.317
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN235
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 10 条
  • [1] NAVIGATING THE ROAD TO REIMBURSEMENT AND OPTIMIZING UPTAKE FOR ONCOLOGY AGENTS IN THE EU5: PAYER AND PRESCRIBER PERSPECTIVES ON THE POWER OF PIVOTAL TRIAL DESIGN
    Buckley, N.
    Ammermann, I
    Vinuesa, L.
    Cox, J.
    VALUE IN HEALTH, 2017, 20 (09) : A459 - A459
  • [2] TIME TO REIMBURSEMENT FOR ONCOLOGY DRUGS IN EU5
    Prada, M.
    Berard, I
    Walzer, S.
    Darba, J.
    Greenwood, B.
    VALUE IN HEALTH, 2018, 21 : S47 - S47
  • [3] THE PROMISING FUTURE OF DIGITAL HEALTH: A ROAD TO REIMBURSEMENT IN US & EU5 MARKETS?
    Sheppard, H.
    VALUE IN HEALTH, 2023, 26 (12) : S432 - S432
  • [4] REVIEW OF REIMBURSEMENT DECISION DRIVERS FOR RARE CANCER THERAPIES ACROSS EU5 MARKETS
    Gupta, J.
    Wahal, V. P.
    VALUE IN HEALTH, 2017, 20 (09) : A569 - A569
  • [5] INPATIENT POLICIES AND REQUIREMENTS FOR THE REIMBURSEMENT OF NOVEL THERAPIES OUTSIDE THE DRG IN THE US AND EU5
    Shah, S.
    Koka, N. S.
    Patel, K.
    Ahmad, M.
    Nair, S.
    Syed, A. A.
    Malempati, Y.
    VALUE IN HEALTH, 2023, 26 (06) : S228 - S228
  • [6] ACCESS AND REIMBURSEMENT FOR CURRENT AND EMERGING ALZHEIMER'S DISEASE-MODIFYING THERAPIES IN THE EU5
    Privolnev, Y.
    Blutstein, T.
    Cox, J.
    Reyes, A.
    VALUE IN HEALTH, 2018, 21 : S344 - S344
  • [7] SINK OR SWIM: HOW CAN SLE BIOLOGICS SUCCESSFULLY ACHIEVE OPTIMAL REIMBURSEMENT AND UPTAKE IN THE EU5?
    Privolnev, Y.
    Albacker, C.
    Nasa, M.
    VALUE IN HEALTH, 2019, 22 : S51 - S52
  • [8] IMPACT OF NOVEL ANTI-TUMOR THERAPIES ON MORTALITY IN VARIOUS ONCOLOGY INDICATIONS ACROSS EU5
    Shah, S.
    Matangi, S.
    Malempati, Y.
    Koka, N. S.
    Syed, A. A.
    Nair, S.
    Ahmad, M.
    Patel, K.
    VALUE IN HEALTH, 2023, 26 (06) : S18 - S18
  • [9] Changing treatment patterns in advanced & metastatic melanoma towards targeted therapies in EU5 countries from 2011 to 2015
    Bernhardt, M.
    Schmidt, N.
    Acker, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [10] IDENTIFYING THE KEY CHALLENGES AFFECTING THE REIMBURSEMENT OF CAR-T THERAPIES IN THE EU5 USING A WEB-BASED PORTAL TO ENGAGE PAYERS
    Singh, Kumar K.
    Clapton, G. S.
    Gray, P. M.
    Bhalla, S.
    VALUE IN HEALTH, 2018, 21 : S62 - S62
1